What physiologic changes occur during induction of anesthesia in a patient with adrenal insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Physiologic Changes During Induction of Anesthesia in Adrenal Insufficiency

Patients with adrenal insufficiency undergoing anesthesia induction face life-threatening cardiovascular collapse due to inability to mount a cortisol stress response, manifesting as progressive vasomotor tone loss, impaired alpha-adrenergic receptor responses to vasopressors, and volume-resistant hypotension that can rapidly progress to shock and death if not immediately treated with hydrocortisone 100 mg IV. 1

Critical Pathophysiology During Induction

Cardiovascular Decompensation Cascade

The surgical stress of anesthesia induction triggers a cortisol surge that these patients cannot produce. This leads to:

  • Progressive loss of vasomotor tone - Without adequate cortisol, vascular smooth muscle loses its ability to maintain tone
  • Impaired catecholamine responsiveness - Alpha-adrenergic receptors fail to respond normally to noradrenaline and other vasopressors, making hypotension refractory to standard treatment 1
  • Sequential hemodynamic deterioration: orthostatic hypotension → supine hypotension → shock → cardiovascular collapse and death if uncorrected 1

This is not theoretical - volume-resistant hypotension may be a late or even agonal event, meaning earlier signs must be recognized 1.

Metabolic and Electrolyte Disturbances

Patients develop:

  • Hyponatremia - Particularly severe in primary adrenal insufficiency with aldosterone deficiency, as antidiuretic hormone-induced water retention is unopposed 1
  • Hypoglycemia risk - Especially critical in children who require frequent glucose monitoring 1

Etomidate-Specific Concerns

Etomidate rapidly and powerfully suppresses cortisol production by inhibiting 11-beta-hydroxylase, the final enzyme in cortisol biosynthesis 1. While data on single induction doses are inconclusive, case reports document acute adrenal crisis and cardiac arrest following etomidate use in patients with preexisting adrenal insufficiency 2, 3. The suppression lasts at least 4 hours 4.

Clinical judgment is required, but the safer approach is to avoid etomidate entirely in known adrenal insufficiency or administer stress-dose hydrocortisone before etomidate if its use is unavoidable 1, 2.

Early Warning Signs (Before Hypotension)

Vigilance for these earlier manifestations is essential 1:

  1. Neurologic changes: non-specific malaise, somnolence, obtunded consciousness, cognitive dysfunction
  2. Orthostatic hypotension - Monitor sitting/standing and supine blood pressure
  3. Hyponatremia (though not always present)
  4. Persistent pyrexia - Often misattributed to sepsis

Mandatory Management Protocol

All patients with adrenal insufficiency must receive hydrocortisone 100 mg IV at induction, followed immediately by continuous infusion of 200 mg/24 hours until able to take double their usual oral dose 1. This regimen is preferred over intermittent dosing because continuous infusion maintains plasma cortisol concentrations matching normal stress responses 1.

Special Populations Requiring Higher Vigilance

  • Patients on CYP3A4 inducers (carbamazepine, phenytoin, rifampicin) - may need higher hydrocortisone doses due to increased metabolism 1
  • Obese patients - some experts recommend higher doses, though evidence is limited 1
  • Primary adrenal insufficiency with mineralocorticoid deficiency - particularly vulnerable to hyponatremia and hemodynamic instability 1

Critical Pitfalls to Avoid

  1. Never use dexamethasone alone in primary adrenal insufficiency - it lacks mineralocorticoid activity 1
  2. Do not wait for hypotension to develop - it may be a terminal event 1
  3. Do not withhold steroids if diagnosis is uncertain - short-term glucocorticoid administration carries minimal risk, while withholding can be fatal 1
  4. Do not reduce steroid supplementation while patient remains pyrexial or unstable 1

The 2020 UK guidelines from the Association of Anaesthetists, Royal College of Physicians, and Society for Endocrinology 1 represent the most comprehensive and recent evidence-based approach, emphasizing that if in doubt about the need for glucocorticoids, they should be given as there are no long-term adverse consequences of short-term administration 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.